Skip to content
OpenCapital
Get started

enGene Therapeutics Inc. ENGN Q3 2025 earnings

Reported September 10, 2025 · Before market open

EPS-$0.57Miss by $0.07
EPS estimate-$0.50

Next report

Sep 14, 2026 (in a month)
EPS estimate-$0.47

Versus estimates

Diluted EPS

Q2 2026-$0.43Beat by $0.05Q1 2026-$0.44Beat by $0.11Q4 2025-$0.73Miss by $0.16
Q3 2025-$0.57Miss by $0.07
Q2 2025-$0.51Miss by $0.01Q1 2025-$0.48Miss by $0.11

Ask the moment enGene Therapeutics Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did enGene Therapeutics Inc. report Q3 2025 earnings?
enGene Therapeutics Inc. (ENGN) reported Q3 2025 earnings on September 10, 2025 before market open.
What were enGene Therapeutics Inc. 's Q3 2025 revenue and EPS?
enGene Therapeutics Inc. reported eps of $-0.57 for Q3 2025.
Did enGene Therapeutics Inc. beat estimates in Q3 2025?
EPS missed the consensus estimate of $-0.50 by $0.07.
How did enGene Therapeutics Inc. 's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 78.1% from $-0.32.
Where can I find enGene Therapeutics Inc. 's Q3 2025 SEC filings?
You can read the 10-Q periodic report (0000950170-25-114224) directly on SEC EDGAR. The filing index links above go to sec.gov.